Hester Biosciences' Stock Price Soars 12.21% on Strong Pharmaceutical Performance

Hester Biosciences, a smallcap pharmaceutical company, has seen a significant increase in its stock price on July 25th, 2024. The stock gained 12.21%, closing at Rs 2821.75. This performance has been deemed as 'Hold' by MarketsMOJO, a leading stock market analysis platform.

The stock is currently trading at a price that is 4.37% away from its 52-week high of Rs 2975.6. It has also outperformed the sector by 4.22% on the same day. This marks the second consecutive day of gains for Hester Biosciences, with a total increase of 15.3% in the past two days.

On July 25th, the stock reached an intraday high of Rs 2851, showing a 4.43% increase, and an intraday low of Rs 2668.55, with a decrease of 2.25%. Hester Biosciences is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages.

In comparison to the Sensex performance, Hester Biosciences has outperformed with a 1-day performance of 13.14% while the Sensex has shown a -0.15% performance. In the past month, Hester Biosciences has also outperformed the Sensex with a 1-month performance of 20.60% compared to the Sensex's 2.53% performance.

This increase in stock price for Hester Biosciences can be attributed to the company's strong performance in the pharmaceutical industry. With its consistent gains and outperforming the sector and Sensex, Hester Biosciences is proving to be a promising smallcap company in the pharma industry.